A869 20 mg Pill: gray & white, capsule/oblong, 16mm
The pill with imprint A869 20 mg (Gray & White, Capsule/Oblong, 16mm) has been identified as Methylphenidate Hydrochloride Extended-Release 20 mg and is used for ADHD, Narcolepsy, and Depression. It belongs to the drug class CNS stimulants and is classified as CSA Schedule 2 (High potential for abuse).
Images for A869 20 mg
Methylphenidate Hydrochloride Extended-Release
- Imprint
- A869 20 mg
- Strength
- 20 mg
- Color
- Gray & White
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-3869
See also:
More about methylphenidate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,092)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
Patient resources
Other brands
Concerta, Ritalin, Jornay PM, Ritalin LA, ... +9 more
Professional resources
- Methylphenidate monograph
- Methylin Chewable Tablet (FDA)
- Methylphenidate CD Capsules (FDA)
- Methylphenidate Chewable Tablets (FDA)
- Methylphenidate ER Capsules (FDA)
Other brands
Concerta, Ritalin, Jornay PM, Ritalin LA, ... +10 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.